ReviewCJC pediatric and congenital heart disease2025
Clinical and Imaging Predictors of Poor Prognosis in Ebstein Anomaly.
Review in CJC pediatric and congenital heart disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Timely surgical intervention and risk stratification in patients with Ebstein anomaly: a 20-year retrospective cohort study.International journal of surgery (London, England) · 2026Article
- Complex Considerations for a Complex Disease: Identifying Poor Prognostic Factors in Ebstein's Anomaly.CJC pediatric and congenital heart disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ebstein anomaly is a rare congenital heart condition characterized by the partial or complete absence of tricuspid valve delamination, a variable degree of "atrialization" of the right ventricle, and a redundant anterior leaflet with fenestrations. Tricuspid valve repair or replacement is often necessary to address tricuspid valve regurgitation, yet the timing remains controversial. Early intervention risks multiple reoperations, whereas disease progression may cancel the benefits of a delayed intervention. Clinical, biological, imaging, and electrocardiographic markers of poor prognosis may help determine when to intervene. Transthoracic echocardiography and cardiac magnetic resonance imaging are imaging modalities of choice to detect prognostic markers in the context of severe tricuspid regurgitation. This review summarizes established and emerging prognostic factors that may help to individualize the timing and planning of surgery for patients with Ebstein anomaly.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.